Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...

Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

The MarketBeat consensus price target on JNJ is around $173, implying just 5% to 6% upside. That average rises slightly to ...

Shares of Johnson & Johnson broke out of a classic ascending triangle pattern. They have since stalled out at resistance.

Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

Johnson & Johnson earnings came in 3% higher than consensus. The company's operating leverage was "slightly diluted by higher ...

Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...

Johnson & Johnson (NYSE: JNJ) ranks among the best forever stocks to invest in. Prior to the company’s second-quarter ...

With economic uncertainty looming in the second half of 2025, as well as lingering inflationary pressures and potential interest rate changes, investors are becoming more cautious about where to ...